Skip to main content

Call for Papers: Deep learning the genome

Hereditas is calling for submissions to our Collection on "Deep learning the genome".

Featured Article: Can Omega-3 prevent the accidence of stroke: a mendelian randomization study

New Content Item (2)The lipid-lowering effects of Omega-3 fatty acids have been widely reported, yet their impact on ischemic stroke remains controversial. Reports on the protective effects of unsaturated fatty acids, such as Omega-6 and Omega-7, as well as saturated fatty acids in cardiovascular diseases, including hypertension and ischemic stroke, are less frequent. This study aims to identify fatty acids associated with blood pressure and ischemic stroke through Mendelian randomization. Besides, it seeks to determine whether specific fatty acids can prevent ischemic stroke by managing blood pressure and revealing the specific mechanisms of this action.

© MF3d / Getty Images / iStock

Additional Cover Letter Guidelines

Upon submission, in your cover letter, please include the names of at least five potential reviewers, in the relevant field of research, to review your manuscript. In light of this, please ensure that there are no conflicts of interest.

Aims and scope

Hereditas publishes original cutting-edge research and reviews. As the Official journal of the Mendelian Society of Lund, the journal welcomes research from across all areas of human, plant, animal and microbial genetics and epigenetics. Topics of interest also include cancer genetics, cancer biology, non-coding RNA, Data Mining, and Genome Technology. Find more information here.

Image: 3D Render of DNA

© Muhammad / Generated with AI / Stock.adobe.com

Articles

Previous content

Hereditas launched with BioMed Central in 2015, transferring from its previous publisher Wiley. All back content is available in the archive.

Editors-in-Chief

Ramin Massoumi, Lund University

Dr. Ramin Massoumi is a Professor and Principal Investigator at Lund University, Sweden. After earning a PhD from Lund University and completing postdoctoral training at the Max Planck Inst. for Biochemistry in Germany, Dr. Massoumi now leads a research group focused on cancer biology and the development of novel anticancer drugs. Dr. Massoumi has received several prestigious awards, including grants from the European Research Council and Novo Nordisk. As the founder of the Company IVRS, Dr. Massoumi contributes to cancer research both academically and commercially. In addition to serving on the editorial boards of several journals, Dr. Massoumi became Editor-in-Chief of Hereditas in 2024.

Yongyong Shi, Shanghai Jiao Tong University 

10-year co-Editor-in-Chief of Hereditas. Professor of both Center for Excellence in Brain Science and Intelligence Technology (Institute of Neuroscience), Chinese Academy of Sciences and Bio-X Institutes, Shanghai Jiao Tong University. Research interests include genomic studies of complex traits, etiology of brain disorders, and development of analytical tools with multidisciplinary techniques.



Society information

The Mendelian Society of Lund was founded in 1910 and except for a short break during 1912-1916 has been active ever since. In 1920, the Society started to publish Hereditas, a scientific journal in genetics. In the post-genomic era, the scope of Hereditas has evolved to include any research on genomic analysis.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.1
    5-year Journal Impact Factor: 2.6
    Source Normalized Impact per Paper (SNIP): 0.455
    SCImago Journal Rank (SJR): 0.532

    Speed 2023
    Submission to first editorial decision (median days): 25
    Submission to acceptance (median days): 135

    Usage 2023
    Downloads: 333,351
    Altmetric mentions: 210